Neurologic complications of antiphospholipid antibodies

Robin L Brey, A. E. Gharavi, M. D. Lockshin

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Antiphopholipid antibodies are highly associated with venous and arterial thrombotic episodes, which are often recurrent. Although cerebral and ocular ischemia are the most common neurologic complications of antiphospholipid antibodies, a variety of neurologic syndromes has been associated with them. Recent reports using in vitro systems and animal models strongly suggest that these antibodies may be directly implicated in the pathogenesis of thrombosis rather than simply being markers of a procoagulable state. This article discusses the laboratory diagnosis, clinical features, and treatment of neurologic disease associated with antiphospholipid antibodies.

Original languageEnglish (US)
Pages (from-to)833-850
Number of pages18
JournalRheumatic Disease Clinics of North America
Volume19
Issue number4
StatePublished - 1993
Externally publishedYes

Fingerprint

Antiphospholipid Antibodies
Nervous System
Antibodies
Clinical Laboratory Techniques
Nervous System Diseases
Brain Ischemia
Thrombosis
Animal Models
Therapeutics
In Vitro Techniques

ASJC Scopus subject areas

  • Rheumatology

Cite this

Neurologic complications of antiphospholipid antibodies. / Brey, Robin L; Gharavi, A. E.; Lockshin, M. D.

In: Rheumatic Disease Clinics of North America, Vol. 19, No. 4, 1993, p. 833-850.

Research output: Contribution to journalArticle

Brey, Robin L ; Gharavi, A. E. ; Lockshin, M. D. / Neurologic complications of antiphospholipid antibodies. In: Rheumatic Disease Clinics of North America. 1993 ; Vol. 19, No. 4. pp. 833-850.
@article{9fbd430a547b49e7a46e837335950a05,
title = "Neurologic complications of antiphospholipid antibodies",
abstract = "Antiphopholipid antibodies are highly associated with venous and arterial thrombotic episodes, which are often recurrent. Although cerebral and ocular ischemia are the most common neurologic complications of antiphospholipid antibodies, a variety of neurologic syndromes has been associated with them. Recent reports using in vitro systems and animal models strongly suggest that these antibodies may be directly implicated in the pathogenesis of thrombosis rather than simply being markers of a procoagulable state. This article discusses the laboratory diagnosis, clinical features, and treatment of neurologic disease associated with antiphospholipid antibodies.",
author = "Brey, {Robin L} and Gharavi, {A. E.} and Lockshin, {M. D.}",
year = "1993",
language = "English (US)",
volume = "19",
pages = "833--850",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Neurologic complications of antiphospholipid antibodies

AU - Brey, Robin L

AU - Gharavi, A. E.

AU - Lockshin, M. D.

PY - 1993

Y1 - 1993

N2 - Antiphopholipid antibodies are highly associated with venous and arterial thrombotic episodes, which are often recurrent. Although cerebral and ocular ischemia are the most common neurologic complications of antiphospholipid antibodies, a variety of neurologic syndromes has been associated with them. Recent reports using in vitro systems and animal models strongly suggest that these antibodies may be directly implicated in the pathogenesis of thrombosis rather than simply being markers of a procoagulable state. This article discusses the laboratory diagnosis, clinical features, and treatment of neurologic disease associated with antiphospholipid antibodies.

AB - Antiphopholipid antibodies are highly associated with venous and arterial thrombotic episodes, which are often recurrent. Although cerebral and ocular ischemia are the most common neurologic complications of antiphospholipid antibodies, a variety of neurologic syndromes has been associated with them. Recent reports using in vitro systems and animal models strongly suggest that these antibodies may be directly implicated in the pathogenesis of thrombosis rather than simply being markers of a procoagulable state. This article discusses the laboratory diagnosis, clinical features, and treatment of neurologic disease associated with antiphospholipid antibodies.

UR - http://www.scopus.com/inward/record.url?scp=0027430207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027430207&partnerID=8YFLogxK

M3 - Article

C2 - 8265825

AN - SCOPUS:0027430207

VL - 19

SP - 833

EP - 850

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

IS - 4

ER -